Efficacy of Acupuncture versus Local Methylprednisolone Acetate Injection in De Quervain's Tenosynovitis: A Randomized Controlled Trial  by Hadianfard, Mohammadjavad et al.
Available online at www.sciencedirect.com
Journal of Acupuncture and Meridian Studies
journa l homepage: www. jams-kp i .com
J Acupunct Meridian Stud 2014;7(3):115e121- RESEARCH ART ICLE -Efficacy of Acupuncture versus Local
Methylprednisolone Acetate Injection in De
Quervain’s Tenosynovitis: A Randomized
Controlled TrialMohammadjavad Hadianfard 1, Alireza Ashraf 1,2,
Maryamsadat Fakheri 1,2,*, Aref Nasiri 11Department of Physical Medicine and Rehabilitation, Shiraz University of Medical Sciences,
Shiraz, Iran
2Burn Research Center, Geriatric Research Center, Shiraz University of Medical Sciences,
Shiraz, IranAvailable online 6 November 2013Received: Apr 7, 2013
Accepted: Aug 20, 2013
KEYWORDS
acupuncture;
De Quervain’s disease;
injections;
methylprednisolone* C
4
E
Copy
pISSN
httpacetateorresponding author. Department
4119 Shiraz, Iran.
-mail: maryamfakheri@gmail.com
right ª 2013, International Pharm
2005-2901 eISSN 2093-8152
://dx.doi.org/10.1016/j.jams.201Abstract
There is no consensus on the management of De Quervain’s tenosynovitis, but local corti-
costeroid injection is considered the mainstay of treatment. However, some patients are
reluctant to take steroid injections. This study was performed to compare the efficacy of
acupuncture versus corticosteroid injection for the treatment of this disease. Thirty pa-
tients were consequently treated in two groups. The acupuncture group received five
acupuncture sessions of 30 minutes duration on classic points of LI-5, LU-7, and LU-9
and on ahshi points. The injection group received one methylprednisolone acetate injec-
tion in the first dorsal compartment of the wrist. The degree of disability and pain was
evaluated by using the Quick Disabilities of the Arm, Shoulder, and Hand (Q-DASH) scale
and the Visual Analogue Scale (VAS) at baseline and at 2 weeks and 6 weeks after the start
of treatment. The baseline means of the Q-DASH and the VAS scores were 62.8 and 6.9,
respectively. At the last follow-up, the mean Q-DASH scores were 9.8 versus 6.2 in the
acupuncture and injection groups, respectively, and the mean VAS scores were 2 versus
1.2. We demonstrated short-term improvement of pain and function in both groups.
Although the success rate was somewhat higher with corticosteroid injection,of Physical Medicine and Rehabilitation, Shiraz University of Medical Sciences, Zand Avenue, 71348-
(M. Fakheri).
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116 M. Hadianfard et al.acupuncture can be considered as an alternative option for treatment of De Quervain’s
tenosynovitis.1. Introduction
De Quervain’s tenosynovitis is a stenosing tenosynovitis of
the first dorsal compartment of the wrist. It is caused by
impaired gliding of the abductor pollicis longus (APL) and
extensor pollicis brevis (EPB) tendon sheaths [1]. De Quer-
vain’s tenosynovitis is common among people with jobs that
require repetitive hand movements. Pregnant women and
lactating mothers have also been reported to be in higher
risk due to endocrine influences on fluid retention and/or
mechanical stress on the thumb [2e4]. Although the term
stenosing tenosynovitis is frequently used and tenosynovitis
means the presence of an inflammatory process, histo-
pathological examination of De Quervain’s tenosynovitis
indicates that it does not involve inflammation and
degenerative changes such as myxoid degeneration, fibro-
cartilagenous metaplasia, and deposition of mucopolysac-
charide, and neovascularization is mostly found [5,6].
Diagnosis is based on history and physical examination. The
incidence of De Quervain’s tenosynovitis has been reported
to be 0.5% in men and 1.3% in women in the general pop-
ulation. The highest prevalence has also been reported
among individuals aged 30e50 years old [7].
Treatment of De Quervain’s tenosynovitis can be con-
servative or rarely surgical. Conservative managements
including rest, early immobilization, strapping, heat, cold,
diathermy, transverse friction massage, medications such
as nonsteroidal anti-inflammatory drugs (NSAIDs) in the
early stages, tendon gliding, and strengthening and
eccentric exercises (Eccentric exercise is a special part of
isotonic training. Eccentric contractions occur when the
muscle-tendon unit lengthens) have most widely been
used, but no evidence has been found to support effec-
tiveness of these treatments [1,4,8,9]. Multiple studies
have been conducted to evaluate the efficacy of steroid
injections. A recent review of articles found positive results
of injection compared with other modalities for treatment
of De Quervain’s tenosynovitis [10,11]. Therefore, cortico-
steroid injection remains the most common and effective
treatment option for patients with De Quervain’s
tenosynovitis.
Some of the limitations and failure of injection in
treatment of De Quervain’s tenosynovitis have been
attributed to inaccurate techniques of injection and
anatomic variation in the first dorsal compartment. New
techniques have been described to enhance the accuracy of
injection such as separate injections over the two tendons
or injection under ultrasound guidance [12,13]. The liter-
ature review determined that side effects of local corti-
costeroid injections were relatively mild. However,
irritation, change of skin color, skin atrophy, soft tissue
calcification, skin defect, hypopigmentation, ecchymosis,
and allergic rash were reported [14]. Thus injections have
the potential for adverse events, which may make patients
indecisive to choose them as a treatment option. These
limitations make local steroid injection more challenging toperform. With these realizations, there is an increasing
trend for finding new safe modalities for treatment of
tendinopathies without emphasis on only anti-inflammatory
mechanisms of drugs (NSAIDs or steroids).
Acupuncture for treatment of musculoskeletal disorders
is growing in acceptance by both physicians and patients. It
is one of the best recognized complementary and alterna-
tive medical treatments. Although the classical explanation
of acupuncture’s method of action has been a change in the
Qi or energy flow of the body, many studies have proposed
different mechanisms of action. Local effects include
dilatation of blood vessels, distortion of the connective
tissue, and changes in regional autonomic activity. The
remote endocrine effects consist of release of endorphins
and neurologic effects such as alterations on functional
magnetic resonance imaging of the brain can also occur.
Several pathways of anti-inflammatory actions are also
mentioned [15,16].
To the best of our knowledge, no trial study has been
done addressing the effectiveness of acupuncture treat-
ments in De Quervain’s tenosynovitis. Therefore, the aim of
the present study is to determine the effectiveness of
acupuncture on disability and pain in individuals with De
Quervain’s tenosynovitis.
2. Materials and methods
This randomized clinical study was carried out at physical
medicine and rehabilitation clinics of Shiraz University of
Medical Sciences from October 2012 to April 2013. We
prospectively followed a consecutive series of 30 patients
of any age and either sex with clinical diagnosis of De
Quervain’s tenosynovitis. The patients who had symptoms
and signs of disease (pain and/or swelling around the sty-
loid process of the radius and positive finkelstein test) were
included in the study. All patients underwent routine blood
tests and radiography of the wrist. The patients with onset
of pain less than 4 weeks, recent history of taking NSAIDs,
injection or surgery around the styloid process of the
radius, history of direct trauma, fracture of the wrist, un-
controlled concomitant disease (such as diabetes mellitus
or coagulopathy), abnormal findings in blood tests or radi-
ography of the wrist, and also pregnant or lactating
mothers were excluded from the study. The study was
approved by Shiraz University of Medical Science Ethics
Committees and registered in the Iranian registry of clinical
trials (www.irct.ir) with registration number ID:
IRCT2013012012194N1. The acupuncture process adhered
to the Standards for Reporting Interventions in Controlled
Trials of Acupuncture (STRICTA) criteria [17].
All patients were given a description of the purpose of
the study and the plan of treatments, and the participants
gave their verbal and written consent. These patients were
randomly divided into acupuncture group (n Z 15) and
injection group (n Z 15) using a random allocation
software. In the case group (acupuncture), disposable,
Acupuncture versus injection in De Quervain’s 117sterilized, flexible stainless steel needles (size:
0.25 mm  40 mm) were used. The needles were inserted
into the acupoints LI-5 (Yangxi), LU-7 (Lieque), and LU-9
(Taiyuan). These points were selected based on the me-
ridians contributing to the affected wrist according to
traditional Chinese medicine.
Their locations were decided based on World Health
Organization (WHO) standards. Yangxi is located on the
radial side of the transverse dorsal crease of the wrist,
between the tendons of the extensor pollicis longus and
extensor pollicis brevis muscle (anatomical snuffbox). Lie-
que can be found in the small hollow superior to the styloid
process of the radial bone, 1.5 cun (1 cun is equal to the
breadth of the patient’s thumb) above the distal transverse
crease of the wrist. Taiyuan is located at the lateral end of
the palmar transverse crease of the wrist, on the radial side
(lateral border) of the radial artery and medial to abductor
pollicis longus tendon [18,19]. A maximum of four Ahshi
points (tender point) was also allowed.
We placed the patients in the supine position to make
them more comfortable. The acupuncture group received
five treatment sessions, administered within 1 week. At
each point, the skin was wiped with alcohol and needles
(Ordibehesht Trading. Suzhou Tu’S Acupuncture Medical
Appliance Company (China)) were inserted perpendicularly
to the depth of 0.5 cun without extrarotational or manual
stimulation after needle insertion. The inclination of the
needle was 90 degrees in all points. The needles were left
in place for approximately 30 minutes. All the acupuncture
insertions were performed by a well-trained physiatrist in a
similar fashion.
In the control (injection) group, a mixture of 1 mL of
(40 mg) methylprednisolone acetate (Iran Hormone Phar-
maceutical Company) and 1 mL of 2% lidocaine (Caspian
Tamin Pharmaceutical Company) was injected around the
APL and EPB tendons sheath. The 25-gauge needle (Ava-
pezeshk Company) was inserted 1 cm proximal to the radial
styloid process at an angle of 30e45 degrees from the skin
and parallel to the direction of the tendons. If paresthesia
was experienced, the needle was repositioned to avoid
injuring the superficial radial nerve. The injection was
performed only once. All the patients were advised to avoid
mechanical overload on their hands. The thumb spica splint
was prescribed for patients in both groups. We encouraged
them not to take analgesic drugs during the course of the
study. For cases with bilateral De Quervain’s tenosynovitis,
treatment was done for the more symptomatic side.
Treatment for all patients in both groups was performed
by one physician. Additionally, the physician had the least
possible communication with patients to minimize bias,
especially in the acupuncture group. The primary outcome
measure was Quick Disabilities of the Arm, Shoulder, and
Hand (Q-DASH) questionnaire for evaluation of disability,
i.e., a short version of the full DASH. The Q-DASH is an 11-
item questionnaire (each question is scored between 1 and
5) designed to measure physical function and symptoms in
patients with musculoskeletal disorders of the upper limb.
An increase in scores was interpreted as an increase in the
severity of functional problems from 0 (no disability) to 100
(complete disability). We used the Persian version of Q-
DASH, which has been recently translated and validated for
Iranian people [20].The secondary outcome measure included the 10-cm
horizontal Visual Analogue Scale (VAS) for current pain at
rest. The scoring system was between 0 and 10 (0 repre-
sented no pain and 10 the worst pain comprehensible). Both
of these measures were obtained at baseline, 2 weeks, and
also 6 weeks after the injection and at the end of
acupuncture therapy.
The outcomes were finally assessed according to the
percentage of improvement in disability and pain status
over baseline in each patient as three terms: nearly com-
plete success of treatment (80% or more improvement),
partial success of treatment (60% or more improvement),
and failure of treatment (less than 60% improvement) [12].
The Kolmogorov-Smirnov test was used to check the
normality of the quantitative outcome variables. The Chi-
square test was applied for comparing categorical variables
and t test for quantitative variables between the two
groups. A repeated-measures analysis of variance (ANOVA)
was used to test the changes in VAS and Q-DASH scores
within and between the two groups. Values were presented
as mean  standard deviation (SD). All the analyses were
carried out using SPSS software, version 15.0 (SPSS Inc.,
Chicago, IL, USA). A p value < 0.05 was considered statis-
tically significant.3. Results
A total of 35 patients who fulfilled the inclusion and
exclusion criteria agreed to participate in our study and
were randomly allocated to either the injection or
acupuncture treatment group. Of the 35 patients, three
patients in the acupuncture group dropped out due to an
inability to take time off work, and two patients in the
injection group did not finish the study due to choosing
another treatment option. The dropout rate was low for
both the injection and acupuncture groups. Fig. 1 illus-
trates patient enrollment and random allocation of patients
to the study groups.
There were no statistically significant differences
(p > 0.05) between the two groups in any of the baseline
characteristics. Table 1 shows the baseline characteristics
of two groups. There were six men and 24 women in this
study (80% women). The average age was 40.7 years (range
22e76 years). The right dominant hand was involved in 23
patients, the left dominant hand in two patients, and two
were bilateral. The mean duration from the onset of
symptoms to the first examination was 5 weeks. The pre-
treatment mean Q-DASH score of all patients was 62.8 and
the mean VAS score was 6.9.
At the last follow-up, the mean Q-DASH score decreased
significantly from 61.2 to 6.1 in the injection group and
from 64.4 to 9.8 in the acupuncture group (p < 0.001), and
the mean score of VAS decreased significantly from 6.67 to
1.20 in the injection group and from 7.13 to 2.07 in the
acupuncture group (p < 0.001).
When outcomes were compared between both groups,
the mean Q-DASH score in the acupuncture group was also
somewhat higher than the injection group at 2 weeks (24.3
vs. 13.7) and 6 weeks of follow-up (9.8 vs. 6.1) but statis-
tical significance was not demonstrated between the two
groups (Table 2).
Fulfill inclusion and exclusion criteria n = 39 
Excluded because
patients were not
interested or difficult
to find time to
cooperate n = 4
Total number of patients
randomized n = 35
Randomized to
acupuncture group
n = 18
3 dropped out due to inability
to take time off work
Completed 6 weeks study
n = 15
Randomized to
injection group
n = 17
2 dropped out to choosing
another treatment
Completed 6 weeks study
n = 15
Figure 1 Participant flow diagram.
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slightly higher than that of the injection group at 2 weeks
follow-up and differences were statistically significant (3.9
vs. 2.5), but statistical significance was not demonstrated
between the two groups at 6 weeks of the follow-up (2 vs.
1.2; Table 3).
At the last follow-up in the acupuncture group, 73% of
the patients had partial success of treatment, 53% had
nearly complete success of treatment, and failure was
determined in 27% of patients. In the injection group, 87%
of the patients had partial success of treatment, 80% had
nearly complete success of treatment, and failure was
detected in 13% of patients (Table 4).
Although superiority of injection in improvement of
symptoms over acupuncture was revealed, a significantTable 1 Baseline clinical and demographic characteristics
of patients with De Quervain’s tenosynovitis.
Variable Injection
(n Z 15)
Acupuncture
(n Z 15)
p
Female 11 (73.3) 13 (86.7) 0.65
Age (y) 39.47  12.10 41.93  10.20 0.55
Right wrist 13 (86.7) 10 (66.7) 0.39
Pain duration
(wk)
4.41  2.91 5.74  3.46 0.26
Mean Q-DASH
score
61.2  15.72 64.4  15.06 0.15
Mean VAS
score
6.67  1.75 7.13  1.55 0.79
The values are mean  standard deviation (SD) or n (%).
Q-DASH Z Quick Disabilities of the Arm, Shoulder, and Hand;
VAS Z Visual Analogue Scale.difference from baseline to follow-ups (at 2 weeks and 6
weeks) was observed in both injection and acupuncture
groups (p < 0.001). Acupuncture decreased VAS and Q-DASH
scores over time, somewhat similar to corticosteroid in-
jection treatment (Figs. 2 and 3).
4. Discussion
De Quervain’s tenosynovitis often becomes chronic because
most patients frequently use their hands in daily activities,
which make the healing time prolonged. By contrast, the
nature of the pain mechanism remains unclear and makes
selection of the type of management more challenging [21].
Despite the lack of evidence regarding the effectiveness of
any specific treatment for De Quervain’s tenosynovitis,
relevant published data showed that injection with 83%
cure rate was the most effective management for this
condition [10,22]. Our results, similar to previous clinicalTable 2 Comparison of functional status (Q-DASH score)
between acupuncture and injection groups.
Group Q-DASH
baseline
Q-DASH
2 weeks
Q-DASH
6 weeks
Injection 61.2  15.72 13.7  9.38 6.1  8.52
Acupuncture 64.4  15.06 24.3  12.65 9.8  9.93
Mean
(95% CI)
3.22
(14.74,
8.29)
13.77
(32.98,
5.42)
2.76
(18.81,
13.29)
p 0.185 0.083 0.227
The values are mean  standard deviation (SD).
CI Z confidence interval; Q-DASH Z Quick-disability of the
arm, shoulder and hand.
Table 3 Comparison of pain intensity (VAS score) be-
tween acupuncture and injection groups.
Group VAS baseline VAS 2 weeks VAS 6 weeks
Injection 6.67  1.75 2.53  1.72 1.20  1.61
Acupuncture 7.13  1.55 3.9  1.75 2.07  2.05
Mean
(95% CI)
13.22
(14.47,
5.29)
19.11
(39.28,
1.05)
13.99
(31.49,
3.50)
p 0.071 0.021 0.129
The values are mean  standard deviation (SD).
CI Z confidence interval; VAS Z visual analog scale.
Figure 2 Changes of mean Q-DASH scores for acupuncture
and injection groups over time. Q-DASH score Z Quick Dis-
abilities of the Arm, Shoulder, and Hand score.
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olone acetate injection in treatment of De Quervain’s
tenosynovitis. The only side effect of the injection was
transient pain, which usually lessened or resolved in about
2 days.
Although injection has been considered the mainstay of
management for tendinopathy, the exact mechanism of its
therapeutic effect is unknown. Furthermore, a number of
studies have provided strong evidence that corticosteroid
injection is beneficial in the short term but may be worse
than other conservative interventions in the intermediate
and long terms [23,24].
According to this study, acupuncture improved not only
pain intensity, but also disability status of the patients with
De Quervain’s tenosynovitis. Although we noted a higher
improvement rate in patient’s symptoms in the injection
group, the difference between the two groups was small
when the overall effects were evaluated over time and,
therefore, the efficacy of acupuncture is likewise
remarkable.
To the best of our knowledge, there is no study
comparing acupuncture with standard or sham therapy in
patients suffering from De Quervain’s tenosynovitis. Our
conclusion in this study is supported by the findings of some
previous studies looking at the effect of acupuncture on
tendinopathies. A review by Pfefer et al [25] showed short-
term analgesia from acupuncture in the management of
tendinopathy, but could not provide enough evidence to
support or reject the use of acupuncture treatment. Recent
reviews conducted by Trinh et al [26] and Green et al [27]
provided strong evidence suggesting that acupuncture is
effective in the short-term relief of lateral epicondyle pain.
Another recent study showed that acupuncture improvedTable 4 Outcome of treatment in both groups of patients.
Variable Injection
(n Z 15)
Acupuncture
(n Z 15)
Nearly complete
success
12 (80) 8 (53)
Partial success 13 (87) 11 (73)
Failure 2 (13) 4 (27)
The values are number (%).pain and activity in patients with chronic Achilles tendin-
opathy compared with eccentric exercises [28].
Recently, several studies proposed a new mechanism for
local analgesic effects of acupuncture by the action
through A1 (adenosine) receptors at the target tissue [29].
Acupuncture has shown the potential to increase local
blood flow within a target tissue and affect fibroblastFigure 3 Changes of mean VAS scores for acupuncture and
injection groups over time. VAS Z visual analog scale.
120 M. Hadianfard et al.migration through myofascial collagen manipulation, and
these two mechanisms appear to be the cornerstone in
management of tendinopathies [30,31]. In addition,
acupuncture treatment was well tolerated by patients and
seems to be a safe modality with minimal side effects [32].
The adverse events of acupuncture in our experience were
minimal (like previous studies) and none of the patients
required discontinuation of the sessions. Based on our ob-
servations, mild pain and bruises rarely occurred at the
acupuncture sites and were transient. Also, enhancement
of educational and professional standards in acupuncture
therapy will maximize security and minimize the risk of
adverse events. Although the beneficial effects of
acupuncture treatment may be short term, it seems to be a
very safe and useful modality particularly in patients who
are reluctant to undergo steroid injection or in patients at
high risk for side effects of steroid use, such as lactating
women or diabetic patients. Acupuncture therapy in this
study was not too time-consuming and all sessions were
performed consecutively within 1 week.
Another advantage of acupuncture compared with ste-
roid injection is that it can be performed in more sessions in
intractable cases or repeated if recurrence occurs, without
fear of adverse events. Acupuncture is also a relatively
cost-effective therapy among other modalities.
Despite a similar basic concept, differences in selection
of acupuncture points (near and or remote points) might
have influenced the results and further research is needed
to determine this issue. Another area, when interpreting
the outcomes from our study, was the efficacy of psycho-
social factors, especially in the acupuncture group that
remained uncertain.
Another limitation was the nonblinding method of the
study and we need further studies to blind both participant
and outcome assessor. In this study, we compared
acupuncture with the most standard treatment (steroid
injection). Because acupuncture is not a proven modality in
the treatment of De Quervain’s tenosynovitis, we preferred
to prescribe thumb spica splint for patients in both groups.
Although no definite evidence has been produced to sup-
port the effectiveness of a splint in the treatment of De
Quervain’s tenosynovitis [10], it could have had a con-
founding effect in outcomes assessments.
Unfortunately another limitation of this study was the
short-term follow-up time. The 6-week period may not
have been enough to build up the full effects of the
acupuncture and also definition of the recurrence was not
possible.
Despite the limitations, the present trial shows that
acupuncture can be considered as an effective, well
tolerated, and safe alternative option in the treatment of
patients suffering from De Quervain’s tenosynovitis. Now,
we need to assess long-term effects of acupuncture in large
clinical trials and in comparison with sham interventions
and standard treatments.Disclosure statement
The author affirms there are no conflicts of interest and the
author has no financial interest related to the material of
this manuscript.Acknowledgments
The support of this work, which was part of a thesis for a
degree of specialty, is gratefully acknowledged from the
Vice-Chancellery of Research and Technology of Shiraz Uni-
versity of Medical Sciences, Shiraz, Iran. The authors would
also like to thank Dr Nasrin Shokrpour for editorial assistance.
References
1. Moore JS. De Quervain’s tenosynovitis. Stenosing tenosynovitis
of the first dorsal compartment. J Occup Environ Med. 1997;39:
990e1002.
2. Laoopugsin N, Laoopugsin S. The study of work behaviours and
risks for occupational overuse syndrome. Hand Surg. 2012;17:
205e212.
3. Skoff H. Postpartum/newborn De Quervain’s tenosynovitis of
the wrist. Am J Orthop. 2001;30:428e430.
4. Avci S, Yilmaz C, Sayli U. Comparison of nonsurgical treatment
measures for De Quervain’s disease of pregnancy and lactation.
J Hand Surg Am. 2002;27:322e324.
5. Clarke M, Lyall H, Grant J, Matthewson M. The histopathology
of De Quervain’s disease. J Hand Surg Br. 1998;23:732e734.
6. Knobloch K, Gohritz A, Spies M, Vogt PM. Neovascularisation in
De Quervain’s disease of the wrist: novel combined therapy
using sclerosing therapy with polidocanol and eccentric
training of the forearms and wristsda pilot report. Knee Surg
Sports Traumatol Arthrosc. 2008;16:803e805.
7. Roquelaure Y, Ha C, Leclerc A, Touranchet A, Sauteron M,
Melchior M, et al. Epidemiologic surveillance of upper-
extremity musculoskeletal disorders in the working popula-
tion. Arthritis Rheum. 2006;55:765e778.
8. Peters-Veluthamaningal C, Winters J, Groenier K, Meyboom-
deJong B. Randomised controlled trial of local corticosteroid
injections for De Quervain’s tenosynovitis in general practice.
BMC Musculoskelet Disord. 2009;10:131.
9. Backstrom KM. Mobilization with movement as an adjunct
intervention in a patient with complicated De Quervain’s
tenosynovitis: a case report. J Orthop Sports Phys Ther. 2002;
32:86.
10. Peters-Veluthamaningal C, Van der Windt D, Winters JC, Mey-
boom-de Jong B. Corticosteroid injection for De Quervain’s
tenosynovitis. Cochrane Database Syst Rev. 2009;3:CD005616.
11. Ashraf MO, Devadoss V. Systematic review and meta-analysis
on steroid injection therapy for de Quervain’s tenosynovitis
in adults. Eur J Orthop Surg Traumatol. 2013. http:
//dx.doi.org/10.1007/s00590-012-1164-z.
12. McDermott JD, Ilyas AM, Nazarian LN, Leinberry CF. Ultrasound-
guided injections for De Quervain’s tenosynovitis. Clin Orthop
Relat Res. 2012;470:1925e1931. http://dx.doi.org/10.1007/
s11999-012-2369-5. Epub 2012 May 3.
13. Mirzanli C, Ozturk K, Esenyel C, Ayanoglu S, Imren Y,
Aliustaoglu S. Accuracy of intrasheath injection techniques for
De Quervain’s disease: a cadaveric study. J Hand Surg. 2012;
37:155e160.
14. Brinks A, Koes BW, Volkers ACW, Verhaar JAN, Bierma-
Zeinstra SMA. Adverse effects of extraarticular corticosteroid
injections: a systematic review. BMC Musculoskeletal Disord.
2010;11:206.
15. Lin J-G, Chen W-L. Acupuncture analgesia: a review of its
mechanisms of actions. Am J Chin Med. 2008;36:635e645.
16. Gay RE, Baeu BA, Yang RK. Integrative medicine in rehabilita-
tion. In: Braddom RL, ed. Physical medicine and rehabilita-
tion. 4th ed. Philadelphia: Elsevier Inc,; 2011:491.
17. MacPherson H, Altman DG, Hammerschlag R, Youping L,
Taixiang W, White A, et al. Revised standards for reporting
Acupuncture versus injection in De Quervain’s 121interventions in clinical trials of acupuncture (STRICTA):
extending the CONSORT statement. J Evid Based Med. 2010;3:
140e155.
18. Stux G, Berman B, Pomeranz B. Basics of acupuncture. 5th ed.
Berlin: Springer Verlag; 2003.
19. World Health Organization (WHO). A proposed standard inter-
national acupuncture nomenclature. Geneva: Bull World
Health Organ. 1991;68:165e169.
20. Mousavi SJ, Parnianpour M, Abedi M, Askary-Ashtiani A,
Karimi A, Khorsandi A, et al. Cultural adaptation and validation
of the Persian version of the Disabilities of the Arm, Shoulder
and Hand (DASH) outcome measure. Clin Rehabil. 2008;22:
749e757.
21. Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J
Sports Med. 2009;37:1855e1867.
22. Huisstede BM, van Middelkoop M, Randsdorp MS, Glerum S,
Koes BW. Effectiveness of interventions of specific complaints
of the arm, neck, and/or shoulder: 3 musculoskeletal disorders
of the hand. An update. Arch Phys Med Rehabi. 2010;91:
298e314.
23. Speed C. Corticosteroid injections in tendon lesions. BMJ.
2001;323:382e386.
24. Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of
corticosteroid injections and other injections for management
of tendinopathy: a systematic review of randomized controlled
trials. Lancet. 2010;376:1751e1767.25. Pfefer MT, Cooper SR, Uhl NL. Chiropractic management of
tendinopathy: a literature synthesis. J Manipulative Physiol
Ther. 2009;32:41e52.
26. Trinh K, Phillips S-D, Ho E, Damsma K. Acupuncture for the
alleviation of lateral epicondyle pain: a systematic review.
Rheumatology. 2004;43:1085e1090.
27. Green S, Buchbinder R, Barnsley L, Hall S, White M, Smidt N,
et al. Acupuncture for lateral elbow pain. Cochrane Database
Syst Rev. 2002;1:CD003527.
28. Zhang BM, Zhong LW, Xu SW, Jiang HR, Shen J. Acupuncture for
chronic Achilles tendnopathy: a randomized controlled study.
Chin J Integr Med. 2012. Epub 2012 Dec 21.
29. Goldman N, Chen M, Fujita T, Xu Q, Peng W, Liu W, et al.
Adenosine A1 receptors mediate local anti-nociceptive effects
of acupuncture. Nat Neurosci. 2010;13:883e888. http:
//dx.doi.org/10.1038/nn.2562. Epub 2010 May 30.
30. Kubo K, Yajima H, Takayama M, Ikebukuro T, Mizoguchi H,
Takakura N. Effects of acupuncture and heating on blood vol-
ume and oxygen saturation of human Achilles tendon in vivo.
Eur J Appl Physiol. 2010;109:545e550.
31. Sandberg M, Lundeberg T, Lindberg LG, Gerdle B. Effects of
acupuncture on skin and muscle blood flow in healthy subjects.
Eur J Appl Physiol. 2003;90:114e119.
32. Lao L, Hamilton G, Fu J, Berman B. Is acupuncture safe? A
systematic review of case reports. Altern Ther Health Med.
2003;9:72e83.
